<?xml version="1.0" encoding="UTF-8"?>
<p>Plant-derived quadrivalent seasonal VLP vaccine has been evaluated and elicited cross-reactive antibody and T cell response in healthy adults [
 <xref rid="B82-viruses-12-00518" ref-type="bibr">82</xref>]. Although H7N9 antigens have not been included in this study, the confirmed safety profile of VLP in humans suggests an attractive alternative manufacturing method for producing effective and HA-strain matching influenza vaccines.
</p>
